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Introduction
In recent years, a number of policy documents have empha-
sized trust as a crucial element in the promotion of data 
sharing and international collaboration in research (see, 
e.g., OECD 2014, 2016; OECD and GCOA 2015; European 
Commission 2016). In a decision reached by the European 
Union on May 27 2016 to work towards a paradigm of ‘Open 
Science’ (Council of the European Union 2016), it is written 
that a “trustworthy environment” for the use of samples is 
needed. Similarly, the Committee of Ministers of the Coun-
cil of Europe adopted a recommendation (CM/Rec (2016)6) 
on research on biological materials of human origin empha-
sizing the importance of “earning trust and stressing the role 
of good and transparent governance of biological material 
of human origin stored for research purposes” (Council of 
Europe 2016: preamble). International platforms for research 
such as Public Population Project in Genomics and Society 
(P3G) also propose that “a key element of the success of a 
biobank is the trust and support of the public” (Wallace and 
Knoppers 2012). Concurrently, studies from multiple aca-
demic traditions have discussed trust in relation to participa-
tion in research using human biological material (Nicol et al. 
2016; Lemke et al. 2010; Critchley et al. 2015; O’Doherty 
et al. 2011; Busby 2006; Platt et al. 2015; Cunningham-
Burley 2006). Often one can get the impression that trust 
refers to a particular quality built into the relationships of 
collaboration as a sort of ‘factor’ with a particular effect on 
donations irrespective of context. But how do actual partici-
pants in collaborative international genetic research think 
about trust and the relationships in which they provide bio-
material and health data?
Important bioethical contributions have discussed the role 
of informed consent, privacy and confidentiality in relation 
to data sharing for health related research within a global 
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framework (de Vries et al. 2011; Tassé et al. 2016), and 
empirical studies have sought to understand the interests of 
recruitment staff and researchers, highlighting the practical, 
social, legal and moral dimensions involved in transnational 
health research (Parker and Kingori 2016; Geissler 2013; 
Prainsack et al. 2016). In this study we focus on trust and 
take on the perspective of the individuals providing their 
blood samples and health data for research in a specific 
project. Based on interviews, we compare how donors in 
Pakistan and Denmark who deliver material to the same 
Danish laboratory conceive of ‘trust’ and the nature of their 
research participation. In Denmark the laboratory primarily 
collects material from people with balanced chromosomal 
rearrangements identified through public registers. In Paki-
stan, a national laboratory collects material from people with 
autosomal recessive disorders identified primarily through 
researchers’ personal contacts and snowball sampling. The 
material is then sent to Denmark. The differences between 
these two setups run deeper than that, however, and though 
we are easily lead to think of trust as a ‘factor’ that operates 
in the same way across geographical spaces when reading 
policies of international data sharing, we argue that ‘trust’ 
should not be thought of as the name of a phenomenon char-
acterizing willingness to donate. People participate for much 
more complex reasons, and the ‘trust’ they invest takes many 
different forms. Broad policy references to ‘trust’ might 
divert attention from the hopes and concerns of research 
participants by ‘black-boxing’ what they do invest in the 
relationship with researchers and research projects when 
giving their genetic material and health data. We begin our 
argument by illustrating how ‘trust’ has been shown to have 
many meanings also in the literature.
Academic discourses on trust
The concept of trust is used in multiple disciplines and 
with varying meanings. Some employ it as a descriptive 
and neutral concept; others use it as a prescriptive concept 
and ascribe positive values to it. Simpson (2012) suggests 
dividing the different understandings of trust according 
to three dimensions: affective, rational or normative. The 
affective dimension is described as an attitude of optimism 
towards the goodwill of others (Baier 1986). The rational 
understanding of trust involves seeing it as a forward-
looking function of interest maximization (Coleman 1990). 
With a normative dimension scholars have focused on the 
moral expectation that others ought to do what is ‘right’, 
even in distant relationships (Hollis 1998). Holton (1994) 
bridges the normative and the affective dimensions when 
emphasizing the emotional aspect of expectations associ-
ated with trust: “When you trust someone to do something, 
you rely on them to do it, and you regard that reliance in a 
certain way: you have a readiness to feel betrayal should it 
be disappointed, and gratitude should it be upheld” (Holton 
1994, p. 67). Some scholars have criticized the normative 
uses of ‘trust’, arguing that there is nothing inherently good 
or moral about trust (O’Neill 2002; Jones 2012). Instead 
of focusing on trust, they suggest assessing trustworthiness 
(Hardin 2002; Lehrer 2006; Aitken et al. 2016). Trustwor-
thiness can be understood as ‘good reasons’ to trust. Mis-
placed trust, they argue, can be harmful, for example, when 
there is a discrepancy between the expectations of research 
participants and the interests served by the research insti-
tutions (O’Neill 2002). Hardin (2002) stresses that well-
placed trust is present when the person or institution that 
is trusted is serving the interests of the one investing trust, 
terming this “encapsulated interests”. Acknowledging this 
conceptual diversity, Simpson concludes that trust does not 
refer to a single ‘phenomenon’: “Each way of thinking takes 
some relational situation as paradigmatic, and then builds an 
account of trust around it” (2012, p. 564).
Irrespective of Simpson’s critique, social and ethical stud-
ies of genetic research tend to refer to trust without concep-
tual clarification. Some scholars have scritunized the role of 
trust from an empirical bioethical perspective (De Vries and 
Kim 2008). Typically, “it” (whatever it is) is seen as related 
to the willingness to donate and described as vital to making 
research infrastructures work, essential for the effectiveness 
and success of biobanking research (Emerson et al. 2011). 
Beyond the field of biobanking, trust has been described 
more generally as a determinant for, or effect of ‘support 
to research’, because it builds relationships, provides legiti-
macy and reduces complexity (Gilson 2003; Bussey-Jones 
et al. 2010). This view of trust sees it basically as a means, 
rather than attributing a moral value to it (Sztompka 1999).
In a seminal analysis, Luhmann (1999) from a sociologi-
cal perspective suggested studying trust in social systems 
by looking at what it does. He argued that trust is the name 
for a shortcut to social action that we need when we operate 
in contexts we cannot fully know or scrutinize. He suggests 
that trust and distrust basically do the same: they reduce 
social complexity that otherwise paralyzes our ability to 
act (Luhmann 1999). In practice, however, it is difficult to 
use this approach alone to empirically identify an object of 
study; trust is easily assumed to be there based on its func-
tional characteristics. Furthermore, it ignores the affective 
dimensions also associated with trust by many observers.
So how do we study trust, if it is a concept with many 
meanings and not the name of a singular phenomenon? We 
propose to avoid searching for an understanding of what trust 
really means. Instead we use these aforementioned insights 
to encircle a vocabulary (affective, rational, normative) to 
understand relationships in their specificity, what people 
invest in them and why. We observe the relational qualities 
of ‘trust’, but instead of defining it with specific traits, or as 
reliant on particular ways of evaluating human qualities (cf. 
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Humphrey 1997) we study how people operate in relations 
and use discourses of trust (in which the word acquires dif-
ferent meanings) to make sense of these relations. We thus 
approach trust descriptively rather than prescriptively. What 
we take from Luhmann (1999) is an inspiration to explore 
how trust becomes a meaningful ‘shortcut’ for the people 
who provide their material for research. We show the mul-
tifaceted way the term is used, and therefore question the 
uncritical use of terms like ‘trust-building’. Basically, we 
need to understand what is at stake for the research partici-
pants to unpack the concept of trust currently so popular and 
to reassess its ability to address their hopes and concerns.
Methodology and settings
Because ‘trust’ is referred to in policy papers specifically 
aimed at promoting data sharing and international collabo-
ration, we wanted to compare perceptions among research 
participants in very diverse contexts, yet who contribute 
material to the same research unit. Taking point of depar-
ture in one research laboratory in a high-income country, 
Denmark, and one of its partner-laboratories collecting 
material in a low-income country, Pakistan, we recruited 
research participants from each site following the practices 
and contacts of the respective laboratory undertaking the 
recruitment. We have followed the rules set by the Danish 
Data Protection Agency and a Research Ethics Committee 
in Pakistan. Qualitative research is not subject to research 
ethics committee approval in Denmark.
In Pakistan, Sheikh participated in the fieldtrips through 
which material (such as blood samples, biopsies, clinical 
tests and family history) is collected, and furthermore con-
ducted 19 interviews in the homes of research participants 
with multiple family members. The interviews took place in 
December 2015 and January 2016 in urban and rural areas in 
and around three of the largest cities in Pakistan, while two 
were conducted over the phone. The interviews were primar-
ily conducted in Urdu. Some conversations and seven inter-
views, however, were conducted partly in Punjabi (which 
Sheikh understands but does not speak fluently) with the 
assistance of a translator. Many of the families were living 
in poverty with limited access to health care, education and 
food, and had members suffering from severe diseases. The 
genetically affected families recruited for the laboratory’s 
research are identified through people known to the labora-
tory. To ensure variation, we interviewed families classified 
by the laboratory as belonging to ten disease categories, 
including different types of skin disorders, intellectual dis-
abilities, recurrent pregnancy loss, abnormal growth, and 
other diseases known or imagined to have a genetic factor 
involved. All families agreed to participate.
In Denmark, the laboratory uses a national register of 
cytogenetic test results to identify people with balanced 
chromosomal rearrangements and invite them to participate 
in follow-up research. For some it has been so long since the 
tests were done that they have forgotten about them. When 
filling in a questionnaire for the genetic research project, the 
research participants were also asked whether they could be 
contacted by Hoeyer and interviewed about how they had 
experienced their research participation. Hoeyer conducted 
23 interviews with individual research participants in a uni-
versity office, over the phone or in the homes of the individu-
als, based on the wishes of the research participants (see 
also Hoeyer 2016 for further explication). An additional six 
research participants responded over email. The interviews 
were conducted in Danish. All quotes are translated by the 
authors, and all informants are given pseudonyms.
By participating in our study informants were in effect 
research participants in two projects—one dealing with 
genetics, and one dealing with their views and experiences. 
This duality has informed our analysis throughout, not least 
because many, when when we asked about their relationship 
to the genetic researchers, exemplified what they meant by 
talking about their relationship with us, the interviewers. For 
instance, Steffen, a Danish man, remarked: “[trust] means, 
well, now you have been allowed to record this conversation, 
and that’s fine (…), that’s trust for me,” Similarly Humaira, 
a Pakistani mother of a girl with microcephaly, who was a 
little disappointed about not having heard more from the 
genetic researchers, said that she was pleased to meet Sheikh 
because she gained new hope for her daughter’s treatment. 
In this way she used the interview situation to explain some-
thing about her relationship with the genetic researchers.
In our interviews in both Denmark and Pakistan we 
used the same guiding questions, and also coded the mate-
rial according to the same three broad questions: How do 
research participants talk about trust and their research 
participation? In whom do they claim to invest trust and 
in which way? What would constitute a breach of trust for 
them? These three questions also provide the structure for 
the empirical analysis that follows.
How do research participants talk about trust and their 
research participation?
In the following we illustrate how participants use trust to 
refer to expectations towards ‘something bigger’ than indi-
vidual researchers, though in different ways in Pakistan 
and Denmark. Pakistanis tend to use a religious idiom and 
talk about their donation being in the hands of Allah, while 
Danes tend to use a secular idiom and refer to ‘the system’. 
Neither Danes nor Pakistanis talk about trust as infinite or 
unconditional: participants are aware of risks and that they 
depend on the care of researchers who could choose not 
to care for them. When people nevertheless participate in 
research they have their reasons, but the reasons vary and 
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reflect different landscapes of opportunity, deprivation, hope 
and obligation.
Pakistan
In Urdu there are several options for translating trust, e.g., 
‘itemaad’, ‘itminaan’ and ‘bharosa’. While itemaad and itmi-
naan are words with close connotations to reliability and 
being sure of something, bharosa is often used in a religious 
sense. Bharosa was the most commonly used by research 
participants. Indeed, for most of them discourses of trust 
and faith are entirely interrelated. Khalida, for example, who 
was in her sixties and mother-in-law to one 18-year-old girl 
who had undergone several miscarried pregnancies explains 
trust in this way:
First of all we trust in Allah. We don’t have gold, we 
don’t have a lot of money, we’re just thankful that we 
are alive. So the first thing is that we can’t worry. You 
just have to trust in Allah, He will make things better. 
What will we gain from worrying? He brings a lot of 
disease, a lot of hardship. But he also brings a lot of 
joy.
To some extent, this religious framing reflects the precari-
ous life circumstances in which people search for oppor-
tunities to invest hope, well knowing that they might be 
disappointed. Here, we need to acknowledge the level of 
precarity characterizing their daily lives, and how religious 
understandings shape understandings of disease and hope 
for a cure (Mattingly 2010). Several research participants 
talk about trust as believing in the good intentions of others, 
but then later, like Khalida, refer to Allah as mediating what 
will happen. This belief might be seen as partly reflecting 
what the literature describes as the affective dimension of 
trust (Baier 1986), though the secular philosophical vocabu-
lary does not fully capture the way religion motivates the 
participants. Many use religious proverbs, especially one 
about the Prophet Muhammad having said that, “there is no 
disease that Allah has created, except that He also has cre-
ated its remedy” (Sahih Al-Bukhari 7.582). To participate 
in research is one way of searching for that cure. Faisal, a 
26-year-old man totally invalidated from a severe case of 
myopathy thus states how he has high expectations of the 
research due to his trust in Allah: “He is the one who can 
cure any disease”. These participants thus talk about trust, 
but they do not invest it directly in researchers. Rather, it is 
a religiously mediated trust.
Nadeem, the father of two girls whose disease had a late 
onset, in contrast, expressed great confidence in science per 
se: “Science has made such great success, anything can hap-
pen. Science has come very far!” We should note, however, 
that this man had been sending his daughters to Peers for 
many years. Peer is originally the Urdu title of a spiritual 
guide, but has developed into a type of business where some 
men provide ‘religious services and advice’ for example on 
how to drive out what they identify as evil spirits entering 
the body. Nadeem’s statement should therefore not be seen 
as an unconditional devotion to science, but more as an indi-
cation of what was general for most of the Pakistani inform-
ants: their willingness to embrace anything that can support 
their hope for a cure for their children. Umar and Humaria, 
the parents of a girl suffering from a mild case of microceph-
aly, where her memory is quite affected even though she had 
a high level of self-care and awareness, explained that they 
were happy that researchers came to their village because it 
gave them hope. Humaira described the visit in these terms: 
“We were glad they took the blood (…) they come because a 
treatment is possible, that is obvious. Why would they come 
if there is no treatment?” Here trust is spoken of as embrac-
ing hope in situations where there is little else to provide it. 
This type of trust can be seen as an investment conditioned 
on deprived opportunities. According to McGeer (2008), 
trust and hope are intimately interconnected: our capacity 
to hope supports our capacity to trust (McGeer 2008: 237). 
Considering how unlikely it is that this research will involve 
a cure for the children involved, discourses of hope and trust 
involve a dilemma. If the trust is based on hope for some-
thing that will never come true, is it then similar to what 
philosophers call ‘misplaced trust’ (Hardin 2004) or what 
Appelbaum (Appelbaum et al. 1987) famously tagged ‘a 
therapeutic misconception’? Or does this portray a case of 
‘undue influence’ (Lavery et al. 2007)? Rather than employ-
ing these bioethical categories to define a particular breach 
by context-free international standards, we suggest a need 
to appreciate the specificity of how the terms of enrollment 
engage the ‘trusting’ parties’ sense of opportunity, depriva-
tion and hope.
Other participants stated that trust was not important for 
their choice to donate. Hussain, a man in his forties, thus 
explained: “Giving the sample has nothing to do with trust. 
If they do anything for our betterment, then we have trust.” 
For Hussain, trust is something to be earned in a way that 
combines rational and normative dimensions. Some com-
bined this understanding of trust with a religious framing. 
A woman stated for example that “if they are doing good 
things, thank you, may God bring good things for them. If 
they have any other intention, then God knows better.” Some 
donors thus describe their willingness to donate as reflect-
ing neither force nor trust. Rather, research participation is 
a ‘gamble’, an insecure act involving risks.
Denmark
The Danish word for trust is ‘tillid’ and it has many of the 
same connotations as the English term, though it is rarely 
used in any religious sense. For example, you would not say 
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‘tillid til Gud’ as in the English expression ‘to trust in God’ 
or as in the Urdu term ‘bharosa’. Furthermore, Denmark 
is known as a secular society with few references to reli-
gion in public discourse (Zuckerman 2008). In Denmark, 
research participants often use an idiom of ‘trusting the sys-
tem’, which, though entirely secular, in some ways resembles 
the way Pakistani research participants talk about trusting 
Allah. Christian, a man in his sixties thus explains how he 
has “trust in the system that is for sure” and adds how this 
is his main reason for participating in genetic research and 
in our interview: “That is why I have trust. That is why I am 
sitting here. Because I am a citizen in a proper little country 
where we behave in proper ways.” Similarly, Jens Ole said: 
“The doctors want what is good. And I trust the doctors. 
I trust science. I have full trust in science.”1 Anne-Sophie 
says “I guess I basically have faith in the system, or what-
ever you call it” and Thomas similarly says “I trust them 
to guard [personal information] as they should. There are 
rules for these things in Denmark”. Both Anne-Sophie and 
Thomas also remark that they do not know the specific rules. 
Instead it is as if they build on life-long experiences with the 
services of a welfare state. They see their relationship with 
their country as involving a sense of mutual obligation: for 
them to participate and for the ‘system’ to care for them, 
but the actual uses of their samples remain abstract to them 
and to most of the other participants: they are just used for 
‘research’.
Importantly, however, this seeming sense of confidence 
in a functional ‘system’ is not unconditional. In Denmark, 
every biomedical research project involving the use of sam-
ples is registered and assessments are made by ethical com-
mittees. When Ulla, the mother of a disabled child, talks 
about these ethical committees she says that she expects 
responsible persons to take care of her interests, but then 
continues: “But still… I can’t help doubting, right? (...) No, 
I have to trust that the people working with these things 
will do it in ... in the right way. And that it is to enrich our 
society and not to mess anything up.” This awareness that 
they cannot know if researchers will take care of them is 
a particular type of uncertainty that is constitutive for the 
type of trust Ulla is describing. It would be mistaken to 
think of trust as a substantial belief in others (Gross 2012, 
p. 431). Several research participants mentioned cases of 
data leakages on public figures, including a famous leak of 
information about the sexuality of the prime minister’s hus-
band. Several participants who mentioned such leaks, later 
remarked that they themselves were probably not interesting 
enough for any media to broadcast their data. A sense of 
doubt and awareness of risk is also mentioned by Lisbeth, 
but for her trust is a choice with a greater sense of emotional 
and affective implications (Holton 1994): “What is trust? 
Well it is that you want to stay in another person’s care, and 
that you trust that they won’t hurt you... or harm you, or do 
life-destructive, offensive things. So it’s a big thing of course 
to trust someone else.” Note how she too describes trust as 
a choice that involves a risk. Risks must be accepted, how-
ever, if science is to have any chance of progress, as several 
participants remarked. Unlike the Pakistani participants, 
most of the Danes thus invest in hope for future generations 
rather than expecting alleviation for their own hardship. Cut-
ting across these ideas is not only awareness of the involved 
risks, however, but also a sense of trust being dependent on 
belief in something similar to what Hardin (2004) called 
‘encapsulated interests’; namely that the ‘system’ in most 
cases strives towards the same aims of scientific progress 
as the participants.
Both the way research participants talk about trust, and 
their research participation in Pakistan and Denmark, are 
thus conditioned on very different experiences and life cir-
cumstances. In both countries, people engage in a relation-
ship knowing that they can be let down. What they invest is 
mediated either by divinity (in Pakistan) or by ‘the system’ 
(in Denmark). Nevertheless, it would be erroneous to equate 
the emotional stakes involved in Denmark and Pakistan, and 
it would be to misconstrue the reasons for research participa-
tion if we said that people participate because they ‘trust’ 
researchers. In order to understand further how people con-
strue the relationships they enter through research participa-
tion, we now go on to our second question: In whom do they 
invest (what they personally conceive of as) trust?
In whom do research participants claim to invest trust, 
and how?
In both countries we asked research participants to elaborate 
on who they themselves, as participants, trusted. We did 
so to understand how they assessed the relationships they 
encountered through research, and where they would accept 
their samples being sent. In Denmark, a pattern emerged 
which can be described as a set of concentric circles of 
declining trust, from the health professionals they know, 
to the national health services, to the European Union and 
finally the rest of the world. In Pakistan, in contrast, peo-
ple talk about trust as invested in those closest and furthest 
away, while mistrust is expressed towards the national level. 
In the following we suggest that this could reflect ideas about 
who might potentially help them. The difference between 
Denmark and Pakistan again reveals significant aspects of 
the contextual nature of the relationships in which donations 
are made.
1 Interestingly, there is concurrently an ongoing discussion about a 
‘crisis of trust’ in Denmark, and a recent report indicates increasingly 
lower levels of ‘trust’ in the healthcare system (Mandag Morgen and 
TrygFonden 2016). However, this is not reflected in our material.
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Pakistan
With no genetic registers, Pakistani researchers have to iden-
tify genetic carriers through personal networks. In a society 
with inadequate access to healthcare, most people also navi-
gate disease with the help of networks and the local com-
munity. Patients and their relatives consult family, friends, 
neighbours, doctors or someone they meet in mosques or in 
other contexts where they feel secure. Research participants 
described how they felt obligated towards their family to 
take all the advice they can, both from biomedical health 
professionals and other realms of care. The research project 
enters their lives through this network model when contacts 
are established between named researchers and the suffering 
families through mutual acquaintances. Khadija, an elderly 
woman who could not read or write, explained why she 
thought well of the researchers:
The people who came are literate and well read. They 
were doctors. I tell you, with very good manners, with 
gloves, in a van, they also checked the height of my 
children. (…) It was hot that day so we got bottles [soft 
drink]. In a good manner they checked us, looked at 
us before they left.
Most research participants refer to researchers as ‘doctors’, 
even though some of them were just finishing their gradu-
ate research and not even in medicine. They are, however, 
typically seen as possessing authority and kindness, which 
are characteristics that research participants were looking 
for in their strategy to find a cure for their family members.
In contrast, several of the research participants expressed 
negative feelings when talking about the national health sys-
tem. One father of six boys with myopathy, out of which 
three had passed away, expressed his anger with the gov-
ernment of Pakistan for not having helped him. Through 
digital media, television and 3000 flyers he had tried to seek 
financial help for medical care, and was devastated by the 
fact that the politicians had not reacted. Patients, or their 
families, have to pay for the services of healthcare profes-
sionals, who sometimes are seen as more focused on the 
money than health: “In order to run their own shop they will 
keep you coming over and over again,” as he said.
The state of affairs in Pakistan was also a concern of a 
young man studying for his MBA and taking care of his 
siblings while his parents were abroad:
Here in Pakistan people will shoot you in the fear of 
polio. It is the reality. There are other even worse reali-
ties I can’t discuss. (…) And that is why Pakistan is 
lacking behind in regards to polio. (…) I would also 
be hesitant to agree to a research team coming here. 
But this project was recommended [by close friends].
Here this educated man is appalled by the national situation 
and turns to local networks (friends and family) in search 
of a way of maneuvering. As the Pakistani researchers are 
employed by a national government institution, it can be 
seen as paradoxical that the participants can think so badly 
of national institutions yet still embrace the work of the 
genetic researchers. However, by entering through social 
networks, the researchers are seen as more local and there-
fore not in the same category as the ‘national level’.
Following the general perception that a fake hepatitis vac-
cination campaign was carried out in which DNA samples 
were collected to help the United States track Osama bin 
Laden in 2011, other foreign agencies collecting samples in 
Pakistan for research purposes (also when unrelated to vac-
cinations) became surrounded with anxiety and sometimes 
even seen as a potential threat of terror in their own right. 
Hamza, an invalidated 23-year-old male, had also been wor-
ried about giving the sample because of the risk of terrorist 
acts: “A lot of people are into anything for the money. And 
then they go into terrorist acts.” He elaborated that: “The 
needle they use, you know... There could have been poison in 
it. But no, we, it didn’t happen, not that.” Despite the anxiety 
and spill over of sceptisism from the vaccinations campaigns 
to collections of biomaterial for research, most families were 
noticeably happy that their samples were being sent abroad 
for research and enthusiastically agreed to provide samples 
to researchers. The typical reply was, “Absolutely you can 
send the samples. We don’t mind at all.” How can this be?
We propose that the participants express trust in interna-
tional partners because these partners represent resources 
not otherwise available. Research participants were told that 
laboratories in Pakistan have neither the money nor the tech-
nology to properly analyze the samples: “It costs 2.2 lacks 
[2102 USD] for one test. So people from abroad say that 
they can do this for us,” Sameena explained. In this way, 
‘abroad’ becomes a place of opportunity. They are looking 
for what maximizes their chances for treatment and cure, 
similar to what Coleman (1990) calls the rational dimen-
sion of trust. In most cases research participants were not 
aware about the information from to the consent sheet that 
researchers are supposed to provide verbally about the use 
of samples, but when they did remember something, it was 
the collaboration with international partners. Articulations 
of trust seem to reflect people’s perception of opportunities 
for help more so than processing of information about and 
awareness of procedures and use. We thus find that the spe-
cific information research participants want and remember is 
the information that they can use when dealing with the chal-
lenges of their daily lives. We should not assume that people 
invest ‘trust’ in foreign researchers in any general sense, as 
if they were affectively connected to them. Rather, they trust 
foreign researchers to have an ability to do something, and 
hope this ability will be used in their favor.
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Several families were under the impression that, through 
the international partner, their children might be taken to 
Denmark, Germany or Sweden for diagnostics, treatment or 
drug development. Binish, the mother of three small children 
suffering from Charcot-Marie-Tooth disease for example 
said: “They said that they were going to do some tests in 
Germany, I mean test the blood over there. Then they would 
try to take our kids over there for treatment.” Several others 
also explained that the researchers collecting samples had 
mentioned this as a possibility, if a treatment was found for 
the children. Some had the impression that the ones collect-
ing the samples would cover the charges for the treatment. 
When people want to send their children abroad, it indi-
cates their level of desperation. This should not be glossed 
over as a matter of ‘trust’, as if ‘trust’ could explain their 
research participation: they participate to get help. They are 
trying to get access to resources and possibilities for care for 
themselves or their loved ones (see also, Whyte et al. 2013; 
Bruun 2016).
Denmark
Whereas the Pakistani research participants like the idea 
that their samples are being sent abroad, Danish research 
participants typically invested less and less trust the further 
away their samples and health data would go. Most pre-
ferred research being done within Denmark, but had in fact 
thought very little about what had happened to their sample. 
Maria explained: “My immediate thought is that Denmark 
will protect me the most [long pause] but I have no clue. I 
haven’t given it a thought at all.” Maria thinks that every-
one in Denmark should have their samples and fingerprints 
recorded, and that all health records should be available for 
research in digitized format. She is confident that the tax-
financed National Health Service will make good use of her 
health data. Steffen is also comfortable with the way the 
samples are treated within the Danish system, and referred 
to the ‘high standards’ in Denmark compared to other EU 
countries. However, one informant, Lisbeth, a woman work-
ing in governmental research herself, was skeptical about the 
organization of the Danish research system as she found it 
characterized by an overly lenient use of samples.
Primarily skepticism was articulated when Hoeyer asked 
the Danish participants what they thought about their sam-
ples being sent to, for example, China, in case whole-genome 
sequencing would be cheaper there (the world’s supposedly 
biggest genome sequencing company is situated in Beijing 
and has opened a branch in Denmark). Steffen, among oth-
ers, thought that the risk of abuse of his samples would be 
greater in China, or in other forms of cross-national collabo-
ration. Christian stated that China is “too far away.” Anette 
did not mind samples being sent to China, and would leave 
it up to researchers. She assumed ‘the system’ would know 
what is reasonable.
The distinction between public and private research 
was another way of discussing in whom participants invest 
trust. Some remarked that if their samples were to be sent 
to private companies, they at least would like to be asked 
first (while accepting presumed consent for public uses). 
Some believed that private companies from Denmark were 
“Okay”, as some participants said, but not foreign compa-
nies; others saw all companies as less obliged to care for 
interests other than financial profit. In this way, Danish 
research participants invest trust according to a set of con-
centric circles: the closer to the donor, the more trustworthy; 
and relative distance can be institutional (public/private) or 
geographical (Denmark/EU/China). Moving further away in 
the circles involves risks, but risk-taking can be legitimate 
if something is to be gained: for example, if it is economi-
cally efficient or the right competences are elsewhere. Anne-
Sophie believes the samples should be analyzed where it is 
cheapest: “I think, that [if it is cheaper], they should do what 
makes sense. Logical sense.” Kirsten looks at competencies 
and thinks that China could be fine, because they are “good 
at what they do.” Hence, in some ways the Danes invest trust 
according to some of the same parameters as the Pakistani 
research participants, that is, ability to achieve aims, but 
under structurally different conditions and with a focus on 
risk, rather than an emphasis on hope. The ‘trust’ they talk 
about does not refer to the ‘same’ phenomenon. This point 
becomes even clearer as we now turn to what research par-
ticipants would consider potential breaches of trust.
What would constitute a breach of trust?
Overall, reflections on breaches of trust in Pakistan were 
tied to families’ quest for health, while in Denmark breaches 
of trust were related primarily to disclosure of sensitive 
information or unethical research applications. Research 
participants obviously have different things at stake in the 
two countries. In both places, research participants appeared 
somewhat uncomfortable when asked to speak about poten-
tial breaches in trust. Their reflections on breaches of trust 
give us insights into not only what they understand by trust, 
but also what talking about trust does to and for them.
Pakistan
When Sheikh asked about breaches of trust, Pakistani 
research participants reacted either with skepticism or cat-
egorical denial—or they used the question as an opportunity 
to state their dissatisfaction with researchers. One donor, 
Kauser, responded harshly: “What are you implying?” 
Another donor simply ignored the question, even when 
asked a second and third time. These reactions exemplify 
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how discussion of trust can indicate suspicion and interfere 
with the relationship as such, and not just describe it (Baier 
1986, p. 260). Some categorically stated that nothing could 
undermine their trust in the researchers. In contrast to the 
doubts they had just expressed when talking about what trust 
meant to them, these donors now denied having any worries. 
One father, Nadeem, answered our question saying: “There 
is nothing, we will cooperate, as long as you help our kids, 
we don’t need anything besides that.” He did not wish to talk 
about breaches of trust, because he did not wish to endan-
ger the possibility of receiving help from the researchers. 
Humaira similarly promised that if her daughter was given 
treatment, “we will be cooperative, all the way”. These reac-
tions show how questions about breaches are converted into 
potential tests of a relationship they still depend on. In this 
way, talking about trust can be a way of ‘doing’ relationships 
in particular ways.
Another group of research participants used the topic 
to air their dissatisfaction. For them breaches of trust were 
not hypothetical. Most of these participants had provided 
their samples more than 2 years before Sheikh interviewed 
them. For them the lack of contact from researchers after 
having provided the sample was considered a breach of trust. 
Maida, a female donor with recurrent pregnancy loss was 
dismayed because she had expected researchers to tell her 
the reason why she had had three miscarriages. Her main 
reason for donating her fetus and blood sample to research 
was to understand why “her baby wasn’t growing” and she 
explicitly said that she would never donate her fetus again, 
even if it was for the “betterment of others.” Many framed 
lacking response from the researchers as betrayal: “They 
said they would stay in touch, but they didn’t contact us 
at all” and “they just took the blood and left, even though 
they said they would come back.” This clearly depicts a dis-
crepancy between the expectations of research participants 
and the work and possibilities of the research institutions. 
Indeed, most researchers in Pakistan want to help the fami-
lies, change consanguineous patterns and benefit society. 
They too have hopes and concerns, but they are just like the 
research participants, limited by their resources.
Denmark
The Danish research participants had not given breaches 
of trust much thought prior to the interviews. When asked, 
many focused on data leakage and confidentiality issues, as 
already mentioned above. Others said that if their sample 
was used for something other than what the researchers had 
said they would use it for, it would challenge their trust. 
Interestingly, they could not remember what they had agreed 
to in the first place. Some people relate ‘breaches of trust’ 
to unethical research purposes. However, what is seen as 
‘unethical’ differs among the research participants. Lisbeth 
explained that it is not legitimate to enhance knowledge just 
for the sake of getting to know more. It has to promote health 
and wellbeing. Niklas said it would be a breach of trust if 
biological weapons were to be developed using his sample, 
while Morten mentioned cloning as a potential breach of 
trust, and Steffen mentioned bodily enhancement, such as 
muscle increase. None of the concrete examples are relevant 
for the research conducted by the laboratory, and for the 
research participants they probably sprung to mind only as 
a consequence of being asked an unexpected question. Other 
research participants were concerned about research that no 
longer focused on health, but things like identifying criminal 
genes, genes for sexuality, fraud and so on. Research that 
would only focus on commercial gain was also mentioned. 
So whereas breaches of trust in Pakistan can be a concrete 
experience and relate to people’s struggle for health, contem-
plation of breaches of trust are in Denmark more hypotheti-
cal and related to privacy and respect for personal values.
Conclusion
In this paper we have problematized the tendency in policy 
documents to refer to trust as a particular ‘factor’ with a 
given effect on donations irrespective of context. Just as the 
literature contains many different concepts of trust, our anal-
ysis illustrates how references to ‘trust’ can do many differ-
ent things for research participants in different settings. Our 
analysis indicates that there are variations in how research 
participants conceive of trust both between and within Paki-
stan and Denmark (Table 1). We do not wish to generalize 
these findings beyond the particular collaboration that we 
studied, on the contrary, we wish to emphasize that these 
differences and variations should not be read as reflections 
of different ‘cultures’ or static modes of trusting. In differ-
ent contexts and situations, people have different hopes and 
concerns, different opportunities and different cosmologies. 
When participants discuss trust they are trying to shape their 
relationship(s) with researchers while simultaneously com-
municating important hopes and fears in light of their situ-
ation. The generalization we propose is therefore not one 
about what trust means in Pakistan or Denmark, but one 
about how to approach the issue of trust: we should avoid 
thinking of trust as a factor with a particular meaning and 
effect, and instead explore what people invest in research 
collaborations and why.
We could use our observations of divergent meanings of 
trust to dismiss the concept altogether, but then we would 
also limit our understanding of the concerns that people seek 
to communicate with it. Instead, we suggest opting for a 
more nuanced conceptual understanding of trust. Our point 
is to show that variations in conception are determined by 
how the term is used, i.e. what trust does for these people, 
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and thus highlight the contextual nature of the relationships 
in which donations are made and what references to trust do 
for them in these relations.
There are many reasons why policies of data sharing and 
international collaboration focus on harmonization. Simple 
and harmonized rules make collaboration easy. However, 
when harmonization does not take into account local inter-
ests, it risks jeopardizing the sustainability of the very type 
of research the policies were produced to promote. Casual 
references to ‘trust’ in policy documents gloss over these 
significant differences, and thereby risk de-politicizing basic 
inequalities in access to healthcare. Glib policy statements 
about ‘trust’ can end up legitimizing use of people’s dona-
tions (following an implicit argument of the type “we can 
use this biomaterial because we would not have it if people 
did not trust us”), without paying adequate attention to the 
actual reasons people have for participating in research.
In Pakistan, unfulfilled expectations today pose a prob-
lem for future sampling, as seen when disappointed research 
participants refuse to take part in resampling. The current 
way of collecting samples and considering trust in instru-
mental terms thus constitutes a problem for both moral and 
practical reasons. It has been acknowledged as such by the 
laboratory in Pakistan, but it takes international recognition 
to change the conditions under which they collect material. 
In Denmark, similarly, researchers take great care to follow 
up on donor concerns, but most of this work is considered 
irrelevant by funding agencies and is done by dedicated 
researchers as an extra activity (Hoeyer et al. 2017). In Paki-
stan, most of the work researchers would like to do to help 
participants also remains unfunded. Data collectors play an 
Table 1  Summary of key 
findings comparing dominant 
perceptions of trust in Pakistan 
and Denmark with regard to 
three key aspects
Pakistan Denmark
How do research 
participants talk 
about trust and 
their research 
participation?
- Research participants describe trust as mediated by 'something 
bigger', not directly invested in researchers.
- The types of trust people talk about are never unconditional, but 
involve awareness of uncertainties and risks.
- They use a religious idiom
to describe their 
participation and the trust 
they articulate is often 
mediated by divinity.
- They express a high level of 
emotional stakes involved in 
providing their samples and 
information about their 
health and family relations.
- They use a secular idiom to 
describe their participation and the 
trust they articulate is typically 
mediated by ‘the system’.
- They describe a sense of mutual 
obligation: for them to participate 
in research and for the ‘system’ to 
care for them.
In whom do they 
claim to invest 
trust and in 
which way?
- Who they claim to trust reflect ideas about who might potentially 
help them or the research process.
- They claim to invest trust in 
local communities and 
international institutions. 
They express negative 
emotions about national 
institutions.
- A pattern emerged which can be 
described as a set of concentric 
circles of declining trust, from the 
health professionals they know, to 
the national health services, to the 
European Union and finally the 
rest of the world.
What would 
constitute a 
breach of trust 
for them?
- Research participants' reflections on breaches of trust inform us about 
what talking about trust does to and for them. 
- They reacted with either 
skepticism, categorical 
denial of any possible 
breach, or used the question 
as an opportunity to state 
their dissatisfaction with 
researchers.  
- These reactions reflect 
peoples hope for treatment 
or help.
- For them breaches of trust is 
hypothetical and relate to 
disclosure of sensitive information, 
i.e. privacy and respect for 
personal values. 
- 'unethical' research application, i.e. 
research that does not promote 
health and wellbeing. 
The findings are separated into what they share and how they differ. It is important not to essentialize 
these similarities and differences, but instead use the awareness of potential differences to explore what 
trust means and does for people in actual processes of recruitment in these and other countries
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important role in shaping legitimate practices when inter-
acting with research participants and community members 
(Kingori 2013). Harmonization and easy references to trust 
must not become a reason for disregarding what is actu-
ally at stake for participants in their local context. In many 
low-income contexts, people do not donate because of trust; 
they need to trust to donate; and they need to donate to opt 
for help. The sustainability of future international research 
infrastructures depends on the ability of research institutions 
to understand how they affect the lives of the research par-
ticipants, and explorations of local understandings of trust 
can be a good place to start.
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